IP Library Granted Patent US 7,611,851
Granted Patent B2
US 7,611,851 · App. 11/658,345 · Granted Nov 3, 2009

Patent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,611,851
App. No.
11/658,345
Granted
Nov 3, 2009
Kind
B2
Abstract

A Canis sphingosine-1-phosphate (S1P) receptor isoform 1 (cS1P 1 ), the nucleic acid encoding the cS1P 1 receptor, and methods for using the cS1P 1 receptor and the nucleic acid encoding the cS1P 1 receptor in assays for identifying analytes which modulate activity of the cS1P 1 receptor.

Claims (12)

1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a Canis sphingosine-1-phosphate isoform 1 (cS1P 1 ) receptor which comprises the amino acid sequence set forth in SEQ ID NO:2.

2. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:1.

3. An isolated protein comprising the amino acid sequence Of SEQ ID NO:2.

4. A method for identifying an analyte that modulates activity of a Canis sphingosine-1-phosphate receptor isoform 1 (cS1P 1 ) receptor, which comprises:

(a) providing a recombinant cell comprising an isolated nucleic acid molecule which encodes a cS1P 1 receptor comprising the amino acid sequence set forth in SEQ ID NO: 2;

(b) incubating the recombinant cell in a medium with the analyte such that the cell expresses the cS1P 1 receptor; and

(c) determining the activity of the cS1P 1 receptor wherein a change in the activity of the cS1P 1 receptor indicates the analyte modulates activity of the cS1P 1 receptor.

5. The method of claim 4 wherein the activity of the cS1P 1 is determined by measuring a change in the intracellular concentration of Ca 2+ in the presence of the analyte.

6. The method of claim 4 wherein the activity of the cS1P 1 is determined by measuring a change in the intracellular concentration of a metabolite selected from the group consisting of inositol triphosphate (IP 3 ) and diacylglycerol (DAG) in the presence of the analyte.

7. The method of claim 4 wherein the activity of the cS1P 1 is determined by measuring a change in the activity of phospholipase C beta (PLC β ) or protein kinase C (PKC) in the presence of the analyte.

8. The method of claim 4 wherein the activity of the cS1P 1 is determined by measuring a change in the synthesis of cyclic AMP (cAMP) in the presence of the analyte.

9. The method of claim 4 wherein the isolated nucleic acid molecule which encodes the cS1P 1 receptor comprises the nucleotide sequence set forth in SEQ ID NO:1.

Assignments (1)
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023870/0001 →